Lynne Sullivan
Director of Finance/CFO at UNITY BIOTECHNOLOGY, INC.
Net worth: 53 053 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jonathan Solomon | M | 47 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 7 years |
| Nathaniel E. David | M | 56 | 15 years | |
| Adam Koppel | M | 54 | 10 years | |
| Gilmore O’Neill | M | 59 | 20 years | |
| Axel Bolte | M | 52 | 9 years | |
| Ilan Ganot | M | 50 | 11 years | |
| Anirvan Ghosh | M | 60 | 7 years | |
| Jonas Grossman | M | 50 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 years |
| Caroline Dorsa | F | 64 | 14 years | |
| Keith Leonard | M | 62 | 8 years | |
| Alexander Cumbo | M | 53 | 2 years | |
| Robert Woodman | M | 46 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 6 years |
| Doug Treco Treco | M | 66 | 4 years | |
| TY Howton | M | 52 | 2 years | |
| Russell Greig | M | 71 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 years |
| Sarah Bhagat | M | 38 | 5 years | |
| William Sibold | M | - |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | - |
| Clare Khan | M | 72 | 3 years | |
| Michael Hencke | M | - | 12 years | |
| Alexander Nguyen | M | 47 | 3 years | |
| Margo Roberts | M | 69 | 6 years | |
| Annie Ganot | F | - | 11 years | |
| Sukumar Nagendran | M | 58 | 6 years | |
| Georgia Keresty | M | 62 | 3 years | |
| Alan Moses | M | 76 | 4 years | |
| Edward Williams | M | 68 | 1 years | |
| Michael Samar | M | 51 | 2 years | |
| Stephen Sherwin | M | 75 | 14 years | |
| Naomi Zak | M | - |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | - |
| Nicole Murphy | F | - | 9 years | |
| Eric Rowinsky | M | 67 | 14 years | |
| Paul Berns | M | 57 | 6 years | |
| Reinaldo Diaz | M | 70 | 7 years | |
| Ian Smith | M | 58 | 4 years | |
| Glenn F. Pierce | M | 68 |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | 15 years |
| Camille D. Samuels | F | 52 | 9 years | |
| Ed Mathers Mathers | M | 64 | 7 years | |
| Stefan Riley | M | - | - | |
| Martin Edwards | M | 68 | 7 years | |
| Martin Freed | M | 63 | 6 years | |
| Raj Shah | M | 46 | 7 years | |
| Robert Hopfner | M | 51 | 6 years | |
| Wayne I. Lencer | M | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | 27 years |
| Adam Stone | M | 44 | 9 years | |
| David Thompson | M | - | 6 years | |
| Merav Bassan | M | 59 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 years |
| Gayle Gironda | F | - | 3 years | |
| Jessie Hanrahan | M | 47 | 2 years | |
| Michael Inbar | M | - | 3 years | |
| Sally McAlister | F | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | - |
| Alison Kessler | F | - | 4 years | |
| Yves Sabbagh | M | - | 4 years | |
| Paul Herzich | M | 46 | 2 years | |
| Jenny Marlowe | M | 47 | 1 years | |
| Ying Ming Luk | M | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | 15 years |
| Myriam Golembo | M | 59 | 5 years | |
| Sanjay Subramanian | M | 48 | 2 years | |
| Natacha Gassenbach | F | - | 6 years | |
| Eran Elinav | M | - |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 9 years |
| Rotem Sorek | M | - |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 9 years |
| Jake Elkins | M | - | 7 years | |
| Robin Kramer | F | 58 | 6 years | |
| Ginger Gregory | M | 56 | 7 years | |
| Jessica Swann | F | - |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | 15 years |
| Matthew Winton | M | 46 | 1 years | |
| Assaf Oron | M | 49 | 5 years | |
| Ruediger Weseloh | M | - | 18 years | |
| Soo-Jin Kim | M | - | 2 years | |
| Kurt C. Gunter | M | 69 | 2 years | |
| Gabriel Brooks | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen DiPalma | M | 66 | 2 years | |
| Joel Schneider | M | 39 | 8 years | |
| Joan Mannick | M | 66 | 4 years | |
| William Young | M | 79 | 11 years | |
| James Mullen | M | 65 | 21 years | |
| Stelios Papadopoulos | M | 75 | 15 years | |
| Matthew Bennett Arnold | M | 55 | 8 years | |
| Michel Vounatsos | M | 62 | 6 years | |
| Gregory Covino | M | 59 | 7 years | |
| Gilad D. Hayeem | M | 57 | 5 years | |
| Erez Chimovits | M | 60 | 1 years | |
| Rainer Lichtenberger | M | 65 | 14 years | |
| Craig Eric Schneier | M | 76 | 8 years | |
| Paul Clancy | M | 62 | 16 years | |
| Chirfi Guindo | M | 58 | 5 years | |
| Jeffrey Chodakewitz | M | 68 | - | |
| David Lacey | M | 71 | 2 years | |
| Yaron Breski | M | 46 | 1 years | |
| John J. McCabe | M | 57 | 3 years | |
| Richard Mulligan | M | 69 | 14 years | |
| Eric S. Hoffman | M | 54 | 5 years | |
| Matthew Emmens | M | 72 | 4 years | |
| Jeffrey Capello | M | 69 | 3 years | |
| Karl-Ludwig Kley | M | 72 | 10 years | |
| Gbola Amusa | M | 50 | 5 years | |
| Alexander Denner | M | 54 | 14 years | |
| Brian Posner | M | 62 | 14 years | |
| Robert Nelsen | M | 60 | 9 years | |
| Graham Cooper | M | 54 | 5 years | |
| Robert A. Hamm | M | 72 | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 82 | 82.00% |
| Israel | 15 | 15.00% |
| Germany | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lynne Sullivan
- Personal Network